1. Home
  2. VOYA vs RGEN Comparison

VOYA vs RGEN Comparison

Compare VOYA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOYA
  • RGEN
  • Stock Information
  • Founded
  • VOYA 1975
  • RGEN 1981
  • Country
  • VOYA United States
  • RGEN United States
  • Employees
  • VOYA N/A
  • RGEN N/A
  • Industry
  • VOYA Life Insurance
  • RGEN Medical/Dental Instruments
  • Sector
  • VOYA Finance
  • RGEN Health Care
  • Exchange
  • VOYA Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • VOYA 6.7B
  • RGEN 7.6B
  • IPO Year
  • VOYA 2013
  • RGEN N/A
  • Fundamental
  • Price
  • VOYA $67.20
  • RGEN $144.46
  • Analyst Decision
  • VOYA Buy
  • RGEN Buy
  • Analyst Count
  • VOYA 12
  • RGEN 12
  • Target Price
  • VOYA $85.36
  • RGEN $187.44
  • AVG Volume (30 Days)
  • VOYA 983.5K
  • RGEN 531.4K
  • Earning Date
  • VOYA 02-04-2025
  • RGEN 11-12-2024
  • Dividend Yield
  • VOYA 2.68%
  • RGEN N/A
  • EPS Growth
  • VOYA 3.27
  • RGEN N/A
  • EPS
  • VOYA 6.28
  • RGEN N/A
  • Revenue
  • VOYA $7,859,000,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • VOYA N/A
  • RGEN $2.23
  • Revenue Next Year
  • VOYA $6.88
  • RGEN $10.07
  • P/E Ratio
  • VOYA $10.70
  • RGEN N/A
  • Revenue Growth
  • VOYA 10.94
  • RGEN N/A
  • 52 Week Low
  • VOYA $63.11
  • RGEN $113.50
  • 52 Week High
  • VOYA $84.30
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • VOYA 23.15
  • RGEN 45.89
  • Support Level
  • VOYA $65.87
  • RGEN $143.91
  • Resistance Level
  • VOYA $83.59
  • RGEN $161.24
  • Average True Range (ATR)
  • VOYA 1.77
  • RGEN 6.16
  • MACD
  • VOYA -1.23
  • RGEN -0.96
  • Stochastic Oscillator
  • VOYA 7.61
  • RGEN 12.10

About VOYA Voya Financial Inc.

Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: